{
    "2018-08-06": [
        [
            {
                "time": "",
                "original_text": "智飞生物：九价HPV疫苗已在4个省级单位中标",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "九价HPV疫苗",
                        "中标",
                        "省级单位"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：去年与美年健康签署战略合作协议为框架协议",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "美年健康",
                        "战略合作协议",
                        "框架协议"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "健康管理"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：主营业务为疫苗、生物制品研发，目前生产经营正常",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "主营业务",
                        "疫苗",
                        "生物制品",
                        "研发",
                        "生产经营正常"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：自主产品为最主要的部分利润组成",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "自主产品",
                        "利润组成"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}